Free Trial
→ The 401k Email 70 Million Investors Might Delete (From Brownstone Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$1.19
-0.8%		$1.37
$1.00
▼
$2.23
$16.77M1.73184,029 shs72,162 shs
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$8.61
-0.7%		$8.19
$4.00
▼
$9.10
$39.47M1.4716,553 shs10,309 shs
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
$1.04
-5.5%		$1.32
$0.99
▼
$2.99
$52.33M0.79219,339 shs1.26 million shs
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
$10.86
+0.5%		$10.96
$10.19
▼
$11.64
$54.14MN/A363 shs3,495 shs
10 Best Stocks to Own in Fall 2026 Cover
10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-0.83%-1.24%-17.65%+8.18%-30.00%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-0.69%+2.26%+1.29%+39.10%+39.70%
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
-5.45%-11.86%-30.20%-18.75%+103,999,900.00%
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
-0.20%0.00%-0.70%+0.37%+4.16%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$1.19
-0.8%		$1.37
$1.00
▼
$2.23
$16.77M1.73184,029 shs72,162 shs
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$8.61
-0.7%		$8.19
$4.00
▼
$9.10
$39.47M1.4716,553 shs10,309 shs
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
$1.04
-5.5%		$1.32
$0.99
▼
$2.99
$52.33M0.79219,339 shs1.26 million shs
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
$10.86
+0.5%		$10.96
$10.19
▼
$11.64
$54.14MN/A363 shs3,495 shs
10 Best Stocks to Own in Fall 2026 Cover
10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-0.83%-1.24%-17.65%+8.18%-30.00%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-0.69%+2.26%+1.29%+39.10%+39.70%
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
-5.45%-11.86%-30.20%-18.75%+103,999,900.00%
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
-0.20%0.00%-0.70%+0.37%+4.16%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
2.00
Hold$6.00404.20% Upside
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
2.00
Hold$6.75-21.60% Downside
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
2.60
Moderate Buy$5.00380.77% Upside
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest BNGO, IBAC, HYFT, and HBIO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/28/2026
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSell (E+) ➝ Sell (D-)
10/13/2026
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (E+)
10/8/2026
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSell (D) ➝ Sell (D+)
9/21/2026
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeStrong Sell ➝ Hold
9/2/2026
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSell (E) ➝ Sell (E+)
8/27/2026
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (D+) ➝ Sell (D)
8/18/2026
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (E+) ➝ Sell (E)
8/14/2026
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (D-) ➝ Sell (E+)
8/14/2026
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeHold (C-) ➝ Sell (D+)
8/12/2026
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetSpeculative Buy$6.00 ➝ $7.50
(Data available from 11/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
$28.51M0.58N/AN/A$4.37 per share0.27
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$86.55M0.45$11.64 per share0.74$3.07 per share2.80
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
$11.24M4.40N/AN/A$0.18 per share5.78
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-$26.40M-$3.02N/AN/AN/A-106.58%-78.78%-48.54%11/10/2026 (Estimated)
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-$56.70M-$2.31N/AN/AN/A-11.86%-33.13%-4.80%11/10/2026 (Estimated)
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
-$10.11M-$0.26N/AN/AN/A-105.11%-133.26%-77.78%N/A
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest BNGO, IBAC, HYFT, and HBIO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/10/2026Q3 2026
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-$0.45N/AN/AN/A$8.44 millionN/A
11/10/2026Q3 2026
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-$0.33N/AN/AN/A$21.80 millionN/A
9/14/2026Q1 2027
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
-$0.05-$0.09-$0.04-$0.09$3.25 million$2.73 million
8/14/2026Q3 2026
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
N/A-$0.11N/A-$0.11N/AN/A
8/11/2026Q2 2026
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-$0.21-$0.14+$0.07-$0.64$21.45 million$22.73 million
8/10/2026Q2 2026
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
-$0.67-$0.64+$0.03-$0.64$7.55 million($6.67) million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
N/AN/AN/AN/AN/A
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
N/AN/AN/AN/AN/A
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
N/AN/AN/AN/AN/A
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.11
2.48
1.96
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
4.94
1.87
0.98
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
0.43
1.84
1.75
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
11.35%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
80.87%
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
6.70%
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
N/A

Insider Ownership

CompanyInsider Ownership
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
0.65%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
17.03%
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
6.83%
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Bionano Genomics, Inc. stock logo
BNGO
Bionano Genomics
9713.98 million13.89 millionNo Data
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
3394.55 million3.78 millionNo Data
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
7747.58 million44.33 millionOptionable
IB Acquisition Corp. stock logo
IBAC
IB Acquisition
25.01 millionN/AN/A

Recent News About These Companies

IB Acquisition (NASDAQ:IBAC) Stock Jumps 0.2% - Should You Buy?
November 3 at 2:41 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31174882
IB Acquisition Corp. Announces Date of 2026 Annual Meeting of Stockholders
October 15, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/ib-acquisition-corp-announces-date-of-2026-annual-meeting-of-stockholders-1036631995
IBACR - IB Acquisition Corp. RT EXP 092826
September 29, 2026  |  seekingalpha.comhttps://seekingalpha.com/symbol/IBACR
IB Acquisition Corp. secures new equity and PIPE financing
September 21, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/ib-acquisition-corp-secures-new-equity-and-pipe-financing?utm_source=marketbeat.com&utm_medium=referral
IBAC IB Acquisition Corp.
July 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/symbol/IBAC/sec-filings
IB Acquisition Corp. Common Stock (IBAC) SEC Filings
July 10, 2026  |  nasdaq.comhttps://www.nasdaq.com/market-activity/stocks/ibac/sec-filings
IB Acquisition Corp.
June 12, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/ibac/stock-grader
IB Acquisition Corp. Common Stock (IBAC) Institutional Holdings
April 11, 2026  |  nasdaq.comhttps://www.nasdaq.com/market-activity/stocks/ibac/institutional-holdings
IB Acquisition Extends Business Combination Deadline to September 2026
March 27, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/ib-acquisition-extends-business-combination-deadline-to-september-2026?utm_source=marketbeat.com&utm_medium=referral
IB Acquisition (NASDAQ:IBAC) Major Shareholder Aqr Capital Management Holding Sells 4,619 Shares
March 26, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-ibac-insider-buying-and-selling-2026-03-26/
Major Institutional Investor Makes Notable Move in IB Acquisition Corp. Stock
March 24, 2026  |  tipranks.comhttps://www.tipranks.com/news/insider-trading/major-institutional-investor-makes-notable-move-in-ib-acquisition-corp-stock-insider-trading-news?utm_source=marketbeat.com&utm_medium=referral
IB Acquisition (NASDAQ:IBAC) Shares Down 0.2% – Here’s What Happened
March 4, 2026  |  defenseworld.netD
With 65% institutional ownership, IB Acquisition Corp. (NASDAQ:IBAC) is a favorite amongst the big guns
November 1, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/65-institutional-ownership-ib-acquisition-133051116.html
IB Acquisition (NASDAQ:IBAC) Major Shareholder Aqr Capital Management Holding Sells 195,806 Shares
October 15, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-ibac-insider-buying-and-selling-2025-10-15/
IB Acquisition (NASDAQ:IBAC) Major Shareholder Sells $1,284,244.50 in Stock
October 2, 2025  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-ibac-insider-buying-and-selling-2025-10-02/
IB Acquisition Corp. Extends Business Combination Deadline
September 25, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/ib-acquisition-corp-extends-business-combination-deadline/ar-AA1NhKj9
IB Acquisition (NASDAQ:IBAC) Sees Minor Dip Amid Low Volume Nasdaq Composite
June 27, 2025  |  kalkinemedia.comK
IB Acquisition Corp. - Right Stock Price, Quotes and Forecasts | NASDAQ:IBACR | Benzinga
April 10, 2025  |  benzinga.comhttps://www.benzinga.com/quote/IBACR
IB Acquisition Corp. Rt
March 27, 2025  |  wsj.comhttps://www.wsj.com/market-data/quotes/IBACR/financials/annual/balance-sheet
Trading (IBAC) With Integrated Risk Controls
January 1, 2025  |  news.stocktradersdaily.comN

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bionano Genomics stock logo

Bionano Genomics NASDAQ:BNGO

$1.19 -0.01 (-0.83%)
Closing price 11/4/2026 04:00 PM Eastern
Extended Trading
$1.21 +0.02 (+1.51%)
As of 11/4/2026 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

Harvard Bioscience stock logo

Harvard Bioscience NASDAQ:HBIO

$8.61 -0.06 (-0.69%)
Closing price 11/4/2026 04:00 PM Eastern
Extended Trading
$8.63 +0.02 (+0.19%)
As of 11/4/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

MindWalk stock logo

MindWalk NASDAQ:HYFT

$1.04 -0.06 (-5.45%)
Closing price 11/4/2026 04:00 PM Eastern
Extended Trading
$1.08 +0.03 (+3.37%)
As of 11/4/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.

IB Acquisition stock logo

IB Acquisition NASDAQ:IBAC

$10.86 +0.05 (+0.45%)
As of 11/4/2026 11:08 AM Eastern
This is a fair market value price provided by Massive. Learn more.

IB Acquisition Corp. is a blank check company. It formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. IB Acquisition Corp. is based in Boca Raton, Florida.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas